000 01404 a2200385 4500
005 20250516101408.0
264 0 _c20130321
008 201303s 0 0 eng d
022 _a1932-6203
024 7 _a10.1371/journal.pone.0039552
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRinella, Erica S
245 0 0 _aEfficacy of EGFR inhibition is modulated by model, sex, genetic background and diet: implications for preclinical cancer prevention and therapy trials.
_h[electronic resource]
260 _bPloS one
_c2012
300 _ae39552 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aAzoxymethane
_xtoxicity
650 0 4 _aColorectal Neoplasms
_xchemically induced
650 0 4 _aDiet
650 0 4 _aDisease Models, Animal
650 0 4 _aErbB Receptors
_xantagonists & inhibitors
650 0 4 _aFemale
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aPhosphorylation
650 0 4 _aQuinazolines
_xpharmacology
650 0 4 _aSex Factors
650 0 4 _aTyrphostins
_xpharmacology
700 1 _aThreadgill, David W
773 0 _tPloS one
_gvol. 7
_gno. 6
_gp. e39552
856 4 0 _uhttps://doi.org/10.1371/journal.pone.0039552
_zAvailable from publisher's website
999 _c21917966
_d21917966